July 25, 2016

Rheonix to Highlight Automated Microfluidic Workstation for Molecular Testing at AACC Clinical Lab Expo

Automated technology increases efficiencies and lowers total cost of ownership for laboratories ITHACA, N.Y. — Rheonix Inc., a developer of fully automated molecular testing solutions, will highlight its research-use-only Encompass Optimum™ workstation at the 68th American Association of Clinical Chemistry (AACC) Annual Scientific Meeting and Clinical Lab Expo on July 31-Aug. 4 in Philadelphia, Pennsylvania. The workstation performs fully automated, complex molecular assays in an easy-to-use and economical format, addressing workflow… Read More »
Rheonix receives FDA Emergency Use Authorization for Automated COVID-19 Test.
Learn More